July 6, 2021
FDA: Class I recall of Medtronic angiographic guidewire
Editor's Note
The Food and Drug Administration (FDA) on July 2 identified the recall by Medtronic Vascular of its angiographic guidewire component as Class I, the most serious.
The recall was initiated because the devices were not sterilized before being shipped to hospitals.
The guidewire is used during angiography or other interventional procedures to help place catheters into the vasculature.
There have been 2 complaints and no reported injuries or deaths. Distribution dates were November 23, 2007, to March 29, 2021.
Free Daily News
- C-sections linked to longer recovery, higher pain, sleep problems for new mothers
- AI model grades nursing procedures with near-human precision
- Study: Hospitals can safely cut low-value preop tests before routine surgeries
- New studies highlight opportunities to improve pediatric anesthesia safety, comfort
- Social and behavioral factors emerging as key predictors of recovery quality after surgery
- Hospitals being squeezed: Anesthesia workforce gaps, payer cuts threaten surgery access
- CDC layoffs cripple national injury and overdose tracking, leaving prevention efforts in doubt
- The Joint Commission makes nurse staffing a national performance goal for 2026
- Telehealth in limbo: Providers split on continuing Medicare services during shutdown
- States take aim at outpatient facility fees driving higher commercial health costs
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement